Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

3M forecasts underwhelm, shares fall

(Sharecast News) - Shares in 3M came under pressure on Tuesday, after the industrial conglomerate forecast full-year profits and sales below analyst expectations. The US firm, best known for Post-it notes and Scotch tape, said adjusted total sales growth was likely to be between 0.25% and 2.25% in 2024, reflecting organic sales growth in the range of flat to 2%. Adjusted earnings per share were forecast to come in between $9.35 and $9.75.

Analysts had previously forecast organic sales growth of around 2.7% and EPS of up to $9.81.

As at 1245 GMT, the stock was down 7% in pre-market trading.

The cautious outlook came as 3M posted fourth-quarter numbers showing a 1.9% decline in organic sales to $8bn. However, adjusted EPS strengthened to $2.42 from $2.18, ahead of forecasts.

Mike Roman, chief executive, said: "The fourth quarter capped a strong year for 3M. Throughout 2023 we executed our priorities and delivered on our commitments, including expanding underlying operating margins and cash flow.

"We initiated actions to restructure our organisation and simplify our supply, while progressing with our healthcare spin and addressing legal matters."

3M intends to spin out its healthcare unit in the first half of the current year.

It is part of a wider restructuring programme intended to boost sluggish sales and streamline the business, which has seen it cut thousands of jobs as well as settle long-standing legal issues.

Last summer 3M agreed to pay out $10.3m over a 13-year period over claims it had polluted drinking water with toxic chemicals. It also agreed a $6bn settlement with thousands of veterans who claimed earplugs supplied to the US Army had failed to prevent hearing loss.

3M said its 2024 full-year forecasts continued to assume the healthcare business was part of the company. But they do not include the potential impact of funding amounts due under the legal settlements.

Share this article

Related Sharecast Articles

Vector Capital reports robust year-end financial position
(Sharecast News) - Commercial lender Vector Capital reported continued growth in shareholders' equity while maintaining dividends and implementing prudent bad debt provision policies in its full-year results on Friday.
Quadrise posts progress with Utah partner Valkor
(Sharecast News) - Quadrise updated the market on its collaboration with Valkor Technologies in Utah on Friday, targeting the supply of low sulphur 'MSAR' and 'bioMSAR' to the marine and power sector.
Clean Power Hydrogen reports solid full-year progress
(Sharecast News) - UK-based green hydrogen technology company Clean Power Hydrogen (CPH2) reported solid progress towards the commercial rollout of its membrane-free electrolyser (MFE) technology in its final results on Friday, driven by a revamped engineering team.
Diesel generators arrive for Goldplat's South Africa operations
(Sharecast News) - South Africa and Ghana-focussed Goldplat announced the arrival of diesel generators at its South African operations on Friday.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.